| |
|
 December
8, 2011
Formula Pharmaceuticals featured in BioWorld Today "Looking
for Magic ‘Formula’ in Cancer Maintenance Therapy"
DOWNLOAD PDF
|
|
Formula Pharmaceuticals, Inc. is a privately-held, oncology drug development company advancing novel medicines to address areas of unmet therapeutic need in cancer. Formula’s lead product candidate, FPI-01, is a first-in-class immunotherapeutic in clinical development for the maintenance of first-remission in acute myeloid leukemia (AML) and other cancers. Building upon deep industry expertise in identifying, licensing and developing novel medical approaches, Formula's
focus is on accelerating future life-saving cancer therapies.
Learn
more >
|
|
|
